- Home
- NTRB vs GNTA Comparison
NTRB vs GNTA Comparison
Compare NTRB & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTRB | GNTA |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | Italy |
| Employees | N/A | 9 |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.6M | 33.8M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NTRB | GNTA |
|---|---|---|
| Price | $7.98 | $0.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 98.2K | 53.6K |
| Earning Date | 05-29-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,036,651.00 | N/A |
| Revenue This Year | $30.17 | N/A |
| Revenue Next Year | $3,394.36 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.80 | $0.55 |
| 52 Week High | $9.00 | $10.00 |
Technical Indicators
Market Signals| Indicator | NTRB | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 63.41 | 30.82 |
| Support Level | $3.68 | $0.71 |
| Resistance Level | N/A | $0.74 |
| Average True Range (ATR) | 0.92 | 0.09 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 64.70 | 20.10 |
Price Performance
Historical ComparisonAbout NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is an industrial consolidator focused on acquiring majority or full ownership of privately held, established companies operating in Italian national-security-regulated sectors. Its acquisition activities span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity, with a focus on businesses covered by Italy's Golden Power legislation.